Tag-Archive for ◊ Cardiovascular News ◊

Author:
• Friday, May 20th, 2011

Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced the approval of the EXOSEAL™ Vascular Closure Device in the US. EXOSEAL™ incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure.   ”We are very pleased to announce [...]

Author:
• Thursday, February 03rd, 2011

SAN DIEGO, Jan. 31, 2011 /PRNewswire/ — Volcano Corporation (Nasdaq:VOLC – News) said today that the Superior Court of Massachusetts has issued a decision that ruled in favor of Volcano and its wholly-owned subsidiary Axsun Technologies, Inc., and against LightLab Imaging, Inc., on all of LightLab’s remaining claims for trade secret misappropriation. The 11-page decision [...]

Author:
• Wednesday, January 26th, 2011

SUNRISE, Fla., Jan. 24, 2011 (GLOBE NEWSWIRE) — Bioheart, Inc. (OTCBB:BHRT – News) announced today that it has entered into an agreement with AnC Bio Holdings, Inc., a South Korean biomedical company, and one of its U.S. agents for a $4 million equity investment. Bioheart has designated proceeds from the investment to advance the current [...]

Author:
• Tuesday, December 21st, 2010

12/21/2010 MINNEAPOLIS–(BUSINESS WIRE)–An estimated 1.2 million people in the United States have an abdominal aortic aneurysm (AAA) – a dangerous bulge or ballooning in their bodies’ main artery1 that typically causes no symptoms until it ruptures, which can be deadly – and most of them don’t know it. But for those with a known AAA [...]

Author:
• Monday, December 20th, 2010

St. Jude Medical Inc. phases out its Riata and Riata ST leads for its defibrillators over malfunction concerns. St. Jude Medical Inc. (NYSE:STJ) is removing certain defibrillator leads from the market over concerns that their electrical insulation could cause the devices to malfunction. The St. Paul, Minn.-based medical device maker sent a letter to doctors yesterday [...]

Author:
• Monday, September 20th, 2010

St. Jude Medical Inc. (NYSE: STJ) has made good on its plans to open a plant in the El Coyol Free Zone in Alajuela, Costa Rica, to make heart valves. The medical device company based in Little Canada, Minnesota, plans to invest an estimated $670 million in Costa Rica and employ up to 2,000 of [...]

Get Adobe Flash playerPlugin by wpburn.com wordpress themes